Treatment of infectious complications of acquired immunodeficiency syndrome
- PMID: 2996829
Treatment of infectious complications of acquired immunodeficiency syndrome
Abstract
The infectious complications of the acquired immunodeficiency syndrome (AIDS) are discussed, and the conventional and nonconventional therapies used for these infections are reviewed. The infections most commonly encountered in patients with AIDS are Pneumocystis carinii pneumonia (58%), Candida esophagitis (31%), toxoplasmosis (21%), cytomegalovirus infections (15%), and herpes-simplex virus infections (12%). Pneumocystis carinii pneumonia is the most common life-threatening process in these patients. Trimethoprim-sulfamethoxazole (TMP-SMZ) is considered the drug of choice for its treatment. Oral candidiasis often indicates the progression to AIDS in the high-risk populations of homosexual or bisexual men, intravenous drug abusers, and individuals with hemophilia. Nystatin suspension is commonly used to treat oral candidiasis, while Candida esophagitis demands systemic therapy with ketoconazole. Toxoplasmosis most commonly manifests itself in patients with AIDS as a cerebral mass lesion. The recommended therapy includes sulfadiazine and pyrimethamine. AIDS patients frequently experience protozoal invasion of the intestinal tract with Giardia lamblia, Isospora belli, and Cryptosporidium muris. Various drugs have been tried for these infections, including quinacrine hydrochloride, metronidazole, TMP-SMZ, and spiramycin. Cytomegalovirus (CMV) infections commonly involve the lungs, gastrointestinal tract, eyes, brain, and nervous system. Attempts to treat these disseminated CMV infections with antiviral agents, including acyclovir, have not been successful. However, acyclovir has been found beneficial in the treatment of herpes-simplex virus infections. Multiple infectious complications may occur in patients with AIDS as a result of the cellular-immune deficiency associated with this disease. Until more research is done with AIDS patients, therapy must be based on the data available from the treatment of these infections in immunosuppressed patients without AIDS.
Similar articles
-
Parasitic diseases. Diseases associated with acquired immunodeficiency syndrome.Prim Care. 1991 Mar;18(1):129-52. Prim Care. 1991. PMID: 2011633 Review.
-
HIV infection and AIDS.P N G Med J. 1996 Sep;39(3):174-80. P N G Med J. 1996. PMID: 9795558 Review.
-
Clinical spectrum of infections in patients with HTLV-III-associated diseases.Cancer Res. 1985 Sep;45(9 Suppl):4652s-4654s. Cancer Res. 1985. PMID: 2990702
-
The pathology of AIDS.Public Health Rep. 1988 May-Jun;103(3):246-54. Public Health Rep. 1988. PMID: 2836878 Free PMC article.
-
Opportunistic infection in AIDS.J Indian Med Assoc. 1994 Jan;92(1):24-6. J Indian Med Assoc. 1994. PMID: 8207276
Cited by
-
Clinical and bronchoscopic diagnosis of suspected pneumonia related to AIDS.Br Med J (Clin Res Ed). 1986 Sep 27;293(6550):797-9. doi: 10.1136/bmj.293.6550.797. Br Med J (Clin Res Ed). 1986. PMID: 3094663 Free PMC article.
-
Viral infections in the acquired immunodeficiency syndrome.J Electron Microsc Tech. 1988 Jan;8(1):41-78. doi: 10.1002/jemt.1060080105. J Electron Microsc Tech. 1988. PMID: 2854554 Free PMC article.
-
Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.J Virol. 2003 Oct;77(20):11082-93. doi: 10.1128/jvi.77.20.11082-11093.2003. J Virol. 2003. PMID: 14512556 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical